A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypassDOOLAN, L. A; JONES, E. F; KALMAN, J et al.Journal of cardiothoracic and vascular anesthesia. 1997, Vol 11, Num 1, pp 37-41, issn 1053-0770Article

Relation of Milrinone After Surgery for Congenital Heart Disease to Significant Postoperative TachyarrhythmiasSMITH, Andrew H; OWEN, Jill; BORGMAN, Kristie Y et al.The American journal of cardiology. 2011, Vol 108, Num 11, pp 1620-1624, issn 0002-9149, 5 p.Article

Greater vasopressin-induced vasoconstriction and inferior effects of nitrovasodilators and milrinone in the radial artery than in the internal thoracic arteryWEI WEI; YANG, Cheng-Qin; FURNARY, Anthony et al.Journal of thoracic and cardiovascular surgery. 2005, Vol 129, Num 1, pp 33-40, issn 0022-5223, 8 p.Article

Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shockLINDSAY, C. A; BARTON, P; LAWLESS, S et al.The Journal of pediatrics. 1998, Vol 132, Num 2, pp 329-334, issn 0022-3476Article

Evaluation and Optimisation of Current Milrinone Prescribing for the Treatment and Prevention of Low Cardiac Output Syndrome in Paediatric Patients After Open Heart Surgery Using a Physiology-Based Pharmacokinetic Drug-Disease ModelVOGT, Winnie.Clinical pharmacokinetics. 2014, Vol 53, Num 1, pp 51-72, issn 0312-5963, 22 p.Article

Milrinone Therapy for Enterovirus 71-Induced Pulmonary Edema and/or Neurogenic Shock in Children: A Randomized Controlled TrialCHI, Chia-Yu; TRUONG HUU KHANH; TANG CHI THUONG et al.Critical care medicine. 2013, Vol 41, Num 7, pp 1754-1760, issn 0090-3493, 7 p.Article

Effects of milrinone on left ventricular cardiac function during cooling in an intact animal modelTVEITA, Torkjel; SIECK, Gary C.Cryobiology (Print). 2012, Vol 65, Num 1, pp 27-32, issn 0011-2240, 6 p.Article

Is monitoring milrinone therapy useful in advanced heart failure?VAZIR, A; LEAVER, N; LYSTER, H et al.International journal of cardiology. 2011, Vol 149, Num 3, pp 380-381, issn 0167-5273, 2 p.Article

Effect of Milrinone on Ischemia-Reperfusion Injury in the Rat KidneyNISHIKI, T; KITADA, H; OKABE, Y et al.Transplantation proceedings. 2011, Vol 43, Num 5, pp 1489-1494, issn 0041-1345, 6 p.Article

Milrinone attenuates thromboxane receptor-mediated hyperresponsiveness in hypoxic pulmonary arterial myocytesSANTHOSH, K. T; ELKHATEEB, O; NOLETTE, N et al.British journal of pharmacology. 2011, Vol 163, Num 6, pp 1223-1236, issn 0007-1188, 14 p.Article

Use of milrinone in the management of haemodynamic instability following duct ligationSEHGAL, Arvind; FRANCIS, Johny V; LEWIS, Anthony I et al.European journal of pediatrics. 2011, Vol 170, Num 1, pp 115-119, issn 0340-6199, 5 p.Article

Inhaled milrinone attenuates experimental acute lung injuryBUELTMANN, Moritz; XIANG KONG; MERTENS, Michael et al.Intensive care medicine (Print). 2009, Vol 35, Num 1, pp 171-178, issn 0342-4642, 8 p.Article

Intra-Arterial Milrinone for Reversible Cerebral Vasoconstriction SyndromeBOUCHARD, Manon; VERREAULT, Steve; GARIEPY, Jean-Luc et al.Headache. 2009, Vol 49, Num 1, pp 142-145, issn 0017-8748, 4 p.Article

Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMPHANSON, Madelyn S; STEPHENSON, Alan H; BOWLES, Elizabeth A et al.American journal of physiology. Heart and circulatory physiology. 2008, Vol 64, Num 2, pp 786-793, issn 0363-6135, 8 p.Article

Potential for Pulmonary Protection by Nebulized Milrinone During Warm IschemiaCHEN, F; ZHANG, J; AOYAMA, A et al.Transplantation proceedings. 2008, Vol 40, Num 10, pp 3335-3338, issn 0041-1345, 4 p.Article

Fast relaxation dynamics of the cardiotonic drug milrinone in water solutionsEL-KEMARY, Maged; ORGANERO, Juan Angel; DOUHAL, Abderrazzak et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 11, pp 3086-3091, issn 0022-2623, 6 p.Article

Perioperative pulse contour cardiac output analysis in a patient with severe cardiac dysfunctionJONES, D; STORY, D; PEYTON, P et al.Anaesthesia and intensive care. 2006, Vol 34, Num 1, pp 97-101, issn 0310-057X, 5 p.Article

Effect of milrinone on echocardiographic parameters after single dose in Beagle dogs and relationship with drug-induced cardiotoxicityHANTON, Gilles; GAUTIER, Mathieu; BONNET, Pierre et al.Toxicology letters. 2005, Vol 155, Num 2, pp 307-317, issn 0378-4274, 11 p.Article

Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogsSCHWARTE, Lothar A; PICKER, Olaf; BORNSTEIN, Stefan R et al.Critical care medicine. 2005, Vol 33, Num 1, pp 135-142, issn 0090-3493, 8 p.Article

Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure : Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) studyKLEIN, Liviu; O'CONNOR, Christopher M; LEIMBERGER, Jeffrey D et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 19, pp 2454-2460, issn 0009-7322, 7 p.Article

Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edemaWANG, Shih-Min; LEI, Huan-Yao; HUANG, Mei-Chih et al.Pediatric pulmonology. 2005, Vol 39, Num 3, pp 219-223, issn 8755-6863, 5 p.Article

A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgeryBAILEY, James M; HOFFMAN, Timothy M; WERNOVSKY, Gil et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2004, Vol 31, Num 1, pp 43-59, issn 1567-567X, 17 p.Article

Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinoneFOSSA, Paola; MENOZZI, Giulia; DORIGO, Paola et al.Bioorganic & medicinal chemistry. 2003, Vol 11, Num 22, pp 4749-4759, issn 0968-0896, 11 p.Article

Interplay between inhibition of adenosine uptake and phosphodiesterase type 3 on cardiac function by cilostazol, an agent to treat intermittent claudicationSHENG WANG; CONE, James; FONG, Miranda et al.Journal of cardiovascular pharmacology. 2001, Vol 38, Num 5, pp 775-783, issn 0160-2446Article

Rationale and design of the OPTIME CHF trial : Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureCUFFE, M. S; CALIFF, R. M; ROBINSON, L. A et al.The American heart journal. 2000, Vol 139, Num 1, pp 15-22, issn 0002-8703, 1Article